Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (81)

11

Frequency and outcomes of gastrointestinal symptoms in patients with Corona Virus Disease-19

enthalten in: Indian Journal of Gastroenterology | 2021

von Rogers, H. | Choi, W. | Gowda, N. | +6

12

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

enthalten in: Clinical proteomics | 2021

von Rais, Y. | Fu, Z. | Drabovich, A.

13

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

enthalten in: Clinical proteomics | 2021

von Rais, Y. | Fu, Z. | Drabovich, A.

14

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

enthalten in: Clinical proteomics | 2021

von Rais, Y. | Fu, Z. | Drabovich, A.

15

Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19

enthalten in: Molecular diversity | 2021

von Zandi, M. | Soltani, S.

16

Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2 : A molecular modeling approach

enthalten in: Medical journal, Armed Forces India | 2021

von Choudhury, S. | Moulick, D. | Saikia, P. | +1

17

Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19

enthalten in: Molecular diversity | 2021

von Zandi, M. | Soltani, S.

18

Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19

enthalten in: Molecular diversity | 2021

von Zandi, M. | Soltani, S.

19

Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19

enthalten in: Molecular diversity | 2021

von Zandi, M. | Soltani, S.

20

Coronaviruses in Bats : A Review for the Americas

enthalten in: Viruses | 2021

von Hernández-Aguilar, I. | Lorenzo, C. | Santos-Moreno, A. | +2